News Sanofi London S.E.

Equities

Market Closed - London S.E. Other stock markets 16:30:00 05/07/2024 BST			5-day change	1st Jan Change
91.15 ^EUR	+0.08%		+1.14%	+1.63%

07-05	Sector Update: Health Care Stocks Steady Premarket Friday	MT
07-05	Sector Update: Health Care	MT

Sector Update: Health Care Stocks Steady Premarket Friday	07-05	MT
Sector Update: Health Care	07-05	MT
GlaxoSmithkline Pharmaceuticals Limited Announces Change in Management	07-05	CI
Sanofi's Consumer Health Unit Receives Interest from French State	07-05	MT
Bpifrance eyes investment in Sanofi's consumer health business	07-04	RE
Sanofi - Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	07-04	AQ
Bain Capital, Cinven, Others Said Mulling Bids for Sanofi's Consumer Health Unit	07-04	MT
Bain, Cinven Explore Joint Bid for Sanofi's Consumer Unit, Bloomberg Reports	07-04	DJ
Paul Hudson, CEO of Sanofi: AI to improve organisational efficiency	07-03	MT
Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division	07-03	MT
Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division	07-03	MT
Bain, Cinven Said to Weigh Joint Bid for Sanofi's Consumer Health Division, Bloomberg Reports	07-03	MT
SANOFI : Berenberg reiterates its Buy rating	07-03	ZD
SANOFI : JP Morgan remains Neutral	07-03	ZD
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits	07-03	MT
Sanofi Blockbuster Drug Dupixent Gets First-in-World Approval in Europe for COPD	07-03	MT
Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval	07-03	MT
Sanofi: approval of Dupixent for COPD in the EU	07-03	CF
Sanofi obtains EU approval for Dupixent	07-03	RE
Sanofi, Regeneron Get EU Approval for Dupixent to Treat Respiratory Disease	07-03	DJ